HNGR Hanger

Hanger Announces Findings of Newly Published Study That Reveals Significant Cost Benefits Associated With Earlier Prosthetic Fitting Post-Amputation

Hanger, Inc. (NYSE: HNGR) today announced results of its IMPACT study, which evaluates the impact of overall healthcare costs associated with the timing of definitive fitting and delivery of a lower limb prosthesis following amputation. The IMPACT study utilized the IBM Watson Truven Health Marketscan, a national commercial claims database, and analyzed data on 510 patients with lower limb amputations. Results suggest that delaying or not providing a prosthesis increases direct healthcare costs by approximately 25 percent over the initial 12 months post-amputation. Further, earlier receipt of a prosthesis was associated with reduced direct healthcare spending in the same time period of approximately $25,000. The clinical research was peer reviewed and published in a Medline indexed journal, the respected American Journal of Physical Medicine and Rehabilitation.

“In light of previous studies that have demonstrated a link between prosthetic mobility and quality of life, the fact that a patient can receive a prosthesis as far as nine months post-amputation, with no increased costs compared to someone who does not receive a prosthesis, further demonstrates the holistic value of prosthetic rehabilitation,” stated James Campbell, PhD, Hanger Chief Clinical Officer.

Researchers in the clinical and scientific affairs department of Hanger Clinic, including Shane R. Wurdeman, PhD, CP, FAAOP and Taavy Miller, MSPO, CPO, accompanied by researchers from the University of North Carolina at Charlotte’s Department of Public Health, used generalized linear multivariate modeling to determine differences in direct healthcare costs in the 12 months post-amputation between groups based on timing of prosthesis receipt as well as a control group with no prosthesis. Results showed receipt of a prosthesis within three months post-lower limb amputation yielded a reduced total cost by approximately 25 percent within 12 months following amputation when compared to the no-prosthesis group. Additionally, individuals who still received a prosthesis within nine months post-amputation incurred costs similar to the no-prosthesis group despite the included costs of a prosthesis.

“As the leader in our profession, it is our responsibility to provide objective clinical insight to support professionals in making informed, unbiased decisions about appropriate patient care,” stated Hanger President and Chief Executive Officer Vinit Asar. “Not only does prosthetic care help individuals reintegrate as productive members of society with an improved quality of life, but these findings are significant as they demonstrate the added value of a prosthesis in cost savings to the healthcare system.”

The IMPACT study is an initial manuscript based on review of the Watson data, with additional work to follow. The results of the study are set to be published in an upcoming hardcopy print edition American Journal of Physical Medicine and Rehabilitation, and are available via early release online here: . The IMPACT series is part of a vast collection of landmark research studies already published, or in various stages of publication by Hanger Clinic’s Clinical and Scientific Affairs Department, in collaboration with leading researchers, clinical, and academic institutions. Additional information on previously published research can be found here: .

About Hanger, Inc – Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger, Inc. (NYSE: HNGR) delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger's Patient Care segment is the largest owner and operator of O&P patient care clinics with patient care locations nationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. With over 150 years of clinical excellence and innovation, Hanger's vision is to lead the orthotic & prosthetic markets by providing superior patient care, outcomes, services and value. For more information on Hanger, visit .

EN
02/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Hanger

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Downgrading Utilities and Staples to Market Weight We are starting to see some positive signals that suggest the lows for this bear market may have already been established, or at the very least, that additional downside is limited from here. At the same time, the S&P 500 remains in a 4-month downtrend, and the Russell 2000 (IWM) and Russell Micro-Caps (IWC) remain in 8.5-month downtrends. We need to see these indexes reverse their downtrends (get above 4030-4040 on SPX, $189 on IWM, and $115 o...

 PRESS RELEASE

Hanger Reports Third Quarter 2021 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)-- Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the third quarter and nine months ended September 30, 2021. Financial Highlights Net revenue was $289.8 million for the three months ended September 30, 2021, compared to $256.6 million for the same period in 2020, reflecting growth of 12.9 percent. Net income was $21.1 million for the three months ended September 30, 2021, compared to $6.8 million for the same period in 2020. Income from operations w...

 PRESS RELEASE

Hanger Announces Date of 2021 Third Quarter Earnings Release and Confe...

AUSTIN, Texas--(BUSINESS WIRE)-- Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced it will report its financial results for the third quarter and nine months ended September 30, 2021 after the stock market closes on Monday, November 8, 2021. Hanger's management team will host a conference call with the financial community to discuss the financial results the following morning on Tuesday, November 9 at 8:30 a.m. Eastern time. A live webcast, replay of the call and earnings release, will be available on the Company's Investo...

 PRESS RELEASE

Hanger to Present at the Baird 2021 Global Healthcare Conference

AUSTIN, Texas--(BUSINESS WIRE)-- Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced today that members of its management team will participate virtually in presentations and meetings with institutional investors at the Baird 2021 Global Healthcare Conference taking place September 14-15, 2021. Hanger management will participate in an investor presentation scheduled for Wednesday, September 15, at 3:10 p.m. Eastern time. Investors may access a copy of the presentation, live conference presentation and replay of the webcast on...

 PRESS RELEASE

Hanger Reports Second Quarter 2021 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)-- Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the second quarter and six months ended June 30, 2021. Financial Highlights Net revenue was $280.8 million for the three months ended June 30, 2021, compared to $233.4 million for the same period in 2020, reflecting growth of 20.3 percent. Net income was $10.2 million for the three months ended June 30, 2021, compared to $31.1 million for the same period in 2020. Income from operations was $20.1 mill...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch